| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020162457 |
| P356 | DOI | 10.1007/BF00262767 |
| P698 | PubMed publication ID | 3129204 |
| P2093 | author name string | T Kobayashi | |
| Y Sugiyama | |||
| S Ozawa | |||
| M Inaba | |||
| Y Mitsuhashi | |||
| P2860 | cites work | Anticancer drug pharmacodynamics | Q39819996 |
| Anticancer drugs: effect on the cloning of Raji lymphoma cells in soft agar. | Q44477245 | ||
| Quantitative dose-response relations for the cytotoxic activity of chloroethylnitrosoureas in cell culture | Q48975142 | ||
| Dosage regimen design for pharmaceutical studies conducted in animals. | Q52429035 | ||
| A pharmacokinetic analysis program (multi) for microcomputer | Q52732710 | ||
| Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas. | Q54579562 | ||
| Quantitative clonal growth of mammalian cells: its application for quantitative study of cytocidal action of Mitomycin-C | Q69455757 | ||
| Clinical anticancer pharmacology: some pharmacokinetic considerations | Q69612825 | ||
| Pharmacodynamics of Chemotherapeutic Effects: Dose-Time-Response Relationships for Phase-Nonspecific Agents | Q70730344 | ||
| Concentration and time-dependent inter-relationships for antitumour drug cytotoxicities against tumour cells in vitro | Q71232306 | ||
| Metabolic activation of mitomycin C by liver microsomes and nuclei | Q71617942 | ||
| Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules | Q71718328 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 185-190 | |
| P577 | publication date | 1988-01-01 | |
| P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
| P1476 | title | Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration--time product. | |
| P478 | volume | 21 |
| Q59803910 | (L.) P. Royen Leaf Water Extract Induces Apoptosis in Human Hepatocellular Carcinoma (HepG2) Cells via ERK1/2/Akt1/JNK1 Signaling Pathways |
| Q34771640 | A mathematical model for cisplatin cellular pharmacodynamics. |
| Q41942293 | A mathematical model for thermosensitive liposomal delivery of Doxorubicin to solid tumour |
| Q36858196 | A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei |
| Q40233201 | A precise pharmacodynamic study showing the advantage of a marked reduction in cardiotoxicity in continuous infusion of doxorubicin |
| Q43553544 | Antitumor activity and pharmacokinetics of TAS-106, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine |
| Q52183791 | Application of logistic growth model to pharmacodynamic analysis of in vitro bactericidal kinetics. |
| Q39986942 | Cell cycle checkpoint models for cellular pharmacology of paclitaxel and platinum drugs |
| Q41632267 | Cell-killing activity and kinetic analysis of a novel antitumor compound NC-190, a benzo[a]phenazine derivative |
| Q64072233 | Cisplatin Pharmacodynamics Following Endobronchial Ultrasound-Guided Transbronchial Needle Injection into Lung Tumors |
| Q40181972 | Cisplatin-induced hair cell loss in zebrafish (Danio rerio) lateral line |
| Q44412196 | Combination effect of AC-7700, a novel combretastatin A-4 derivative, and cisplatin against murine and human tumors in vivo |
| Q31719328 | Cyclophosphamide and 5-fluorouracil act synergistically in ovarian clear cell adenocarcinoma cells |
| Q78198994 | Development of a pharmacokinetic/pharmacodynamic (PK/PD)-simulation system for doxorubicin in long circulating liposomes in mice using peritoneal P388 |
| Q55234138 | Different modes of cell-killing action between DNA topoisomerase I and II inhibitors revealed by kinetic analysis. |
| Q42281324 | Implantation treatment method of slow release anticancer doxorubicin containing hydroxyapatite (DOX-HAP) complex. A basic study of a new treatment for hepatic cancer |
| Q71585950 | In vitro investigation of a combination of two drugs, cisplatin and carboplatin, as a function of the area under the c/t curve |
| Q42817957 | Increased sensitivity to long-term 5-fluorouracil exposure of human colon cancer HT-29 cells resistant to short-term exposure |
| Q35093902 | Induction of apoptosis through oxidative stress-related pathways in MCF-7, human breast cancer cells, by ethyl acetate extract of Dillenia suffruticosa |
| Q28485922 | Investigation of the spatiotemporal responses of nanoparticles in tumor tissues with a small-scale mathematical model |
| Q44885986 | Kinetic analysis of 5-fluorouracil action against various cancer cells |
| Q52426060 | Kinetic analysis of the in vitro cell-killing action of neocarzinostatin. |
| Q36910615 | Modeling NSCLC progression: recent advances and opportunities available |
| Q92617950 | Modelling drug transport during intraperitoneal chemotherapy |
| Q55482402 | Neurotoxicity and pharmacokinetics of ventriculolumbar perfusion of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in dogs. |
| Q78199005 | Optimization of antitumor effect of liposomally encapsulated doxorubicin based on simulations by pharmacokinetic/pharmacodynamic modeling |
| Q73850585 | Pharmacokinetic/pharmacodynamic modeling of antitumor agents encapsulated into liposomes |
| Q77811663 | Physicochemical factors for cytotoxic activity in platinum dinuclear complexes with pyrimidine and imide ligands |
| Q52506174 | Prediction of ACNU plasma concentration-time profiles in humans by animal scale-up. |
| Q49129434 | Randomized comparison of intra-arterial versus intravenous infusion of ACNU for newly diagnosed patients with glioblastoma |
| Q40722986 | Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary |
| Q77809322 | Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model |
| Q37217739 | The Role of Bystander Effects in the Antitumor Activity of the Hypoxia-Activated Prodrug PR-104. |
| Q73611462 | The effect of locally implanted complexes of adriamycin-hydroxyapatite complexes on tumor--study of a new alternative treatment for hepatic cancer |
| Q34768920 | Two-mechanism peak concentration model for cellular pharmacodynamics of Doxorubicin |
| Q41646104 | Unusual dynamics of killing of cultured Lewis lung cells by the DNA-intercalating antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide |
Search more.